Azithromycin in Bronchiolitis Obliterans Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Bronchiolitis Obliterans SyndromeGraft RejectionLymphocytic BronchiolitisRespiratory Infection
Interventions
DRUG

Azithromycin

Azithromycin 250 mg daily during 5 days followed by 250 mg three times a week on Mon., Wed. and Fri. during study-period.

DRUG

Placebo

Placebo once daily during 5 days, followed by one placebo three times a week on Mon., Wed. and Fri during rest of study-period.

Trial Locations (1)

B-3000

Katholieke Universiteit Leuven and University Hospital Gasthuisberg, Leuven

All Listed Sponsors
collaborator

University Hospital, Gasthuisberg

OTHER

collaborator

Fund for Scientific Research, Flanders, Belgium

OTHER

lead

KU Leuven

OTHER

NCT01009619 - Azithromycin in Bronchiolitis Obliterans Syndrome | Biotech Hunter | Biotech Hunter